Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Alliance Grants

Institut national de la recherche scientifique

$30,000.00

Synthetic saponins as inhibitors of virus:DC-SIGN interactions _x000d_

FY 2020-21

Summary
HIV infections are a significant health issue worldwide. Current antiretroviral therapy is efficient in helping HIV patients to survive, however it remains ineffective in completely removing the virus from the body and can cause undesirable side effects such as residual inflammation. New antiviral strategies against HIV are thus desirable, which is the main focus of this project. Human immunodeficiency virus (HIV) can bind to human dendritic cells through the DC-SIGN receptor, which is specific to certain carbohydrates (i.e., Lewis-X antigens). We propose to chemically prepare natural compounds (i.e., saponins) bearing Lewis-X antigens, which are non-toxic, readily accessible from birch bark residues, and able to self-assemble into micelles. We will evaluate the capacity of these compounds, in both their molecular and supramolecular forms, to bind with the DC-SIGN receptor and to inhibit the DC-SIGN-mediated HIV infection in cellular models. The project will provide new fundamental knowledge on how sugar moieties affect the capacity of saponins to self-assemble and how these synthetic structures could be used to probe and inhibit the interaction of HIV with a human immune receptor of crucial clinical importance. Ultimately, the proposed research project will give access to a new class of agents to help protect against HIV infection.
Program
Alliance Grants
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
560901-2020
Name nom
Gauthier, Charles
Department département
INRS-Institut Armand-Frappier, Centre
Organization id
56
Institution établissement
Institut national de la recherche scientifique
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2020
Competition year année de concours
2020
Award amount
30000
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1202
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Physical sciences
Area of application fr
Sciences physiques
Research subject code
3702
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Carbohydrates
Research subject fr
Glucides
Installment
inst:1 - 1
Partie
1
Nb partie
1
Application title
Synthetic saponins as inhibitors of virus:DC-SIGN interactions _x000d_
Keyword
NSERC
Application summary
HIV infections are a significant health issue worldwide. Current antiretroviral therapy is efficient in helping HIV patients to survive, however it remains ineffective in completely removing the virus from the body and can cause undesirable side effects such as residual inflammation. New antiviral strategies against HIV are thus desirable, which is the main focus of this project. Human immunodeficiency virus (HIV) can bind to human dendritic cells through the DC-SIGN receptor, which is specific to certain carbohydrates (i.e., Lewis-X antigens). We propose to chemically prepare natural compounds (i.e., saponins) bearing Lewis-X antigens, which are non-toxic, readily accessible from birch bark residues, and able to self-assemble into micelles. We will evaluate the capacity of these compounds, in both their molecular and supramolecular forms, to bind with the DC-SIGN receptor and to inhibit the DC-SIGN-mediated HIV infection in cellular models. The project will provide new fundamental knowledge on how sugar moieties affect the capacity of saponins to self-assemble and how these synthetic structures could be used to probe and inhibit the interaction of HIV with a human immune receptor of crucial clinical importance. Ultimately, the proposed research project will give access to a new class of agents to help protect against HIV infection.
Institut national de la recherche scientifique - $30,… | Canada Spends